Compare Aterian Inc (ATER) vs MakeMyTrip Ltd (MMYT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aterian Inc vs MakeMyTrip Ltd — how do they compare? Aterian Inc trades at $0.49 (market cap $5.32M), while MakeMyTrip Ltd trades at $60.56 (market cap $5.78B). The key difference: MakeMyTrip Ltd is far larger — about 1086.5× Aterian Inc's market cap, and MakeMyTrip Ltd is trading nearer its 52-week high, Aterian Inc nearer its low. Which is the better fit depends on your goals.
| ATER | MMYT | |
|---|---|---|
Market Cap | $5.32M | $5.78B |
Sector | Consumer Cyclical | Technology |
52-Week High | $1.39 | $103.21 |
52-Week Low | $0.36 | $36.30 |
Enterprise Value | $5.90M | $6.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ATER trades at $0.47, down 2.56% today, with a bearish technical signal despite recent earnings beats. The company shows deteriorating fundamentals with revenue declining from $221M in 2022 to $69M in 2025 and negative net margins. However, positive developments include a pending asset sale expected to return $0.85-$1.14 per share to stockholders, with proxy advisors recommending approval.
The stock faces significant fundamental challenges with persistent losses and negative cash flow, but the proposed asset sale provides potential near-term catalyst. Analyst sentiment is divided with 50% buy ratings. Key risks include execution of the asset sale and ongoing operational losses, while the technical picture remains bearish near-term.
MakeMyTrip (MMYT) trades at $60.31, down 0.99% today, with a bullish technical signal supported by moving averages. The company shows strong revenue growth to $978M in 2025 and consistent earnings beats, though Q2 2026 missed expectations. Analyst sentiment remains positive with 73% buy ratings and a 34% upside target. Recent news highlights travel industry momentum despite temporary air-ticketing softness.
Investment outlook appears favorable with strong fundamentals and bullish analyst consensus, though risks include rising debt levels and geopolitical travel disruptions. The stock's high P/E ratio of 267 requires sustained earnings growth to justify valuation. Recent institutional selling by Boston Common Asset Management warrants monitoring for broader sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Aterian Inc
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →
